Will an Israeli vaccine be the solution to new variants?
Injectable and oral vaccines under development in Israel may prove significant in protecting people from mutations of the SARS-CoV-2 coronavirus.
Injectable and oral vaccines under development in Israel may prove significant in protecting people from mutations of the SARS-CoV-2 coronavirus.
With vaccines from several sources soon to enter Israel needing ultra-cold refrigeration, Magen David Adom rolls out special caravans.
Testing of BriLife vaccine developed at Israel Institute for Biological Research begins at Hadassah and Sheba medical centers on healthy volunteers.
Predictions announced at virtual OurCrowd Pandemic Innovation Conference attended by investors, entrepreneurs, executives, officials from 90 nations.
A single dose of a vaccine developed at the Israel Institute for Biological Research protects Syrian golden hamsters against the disease, paper says.
IIBR scientists had good results using an analogue of the FDA-approved Cerdelga and an analogue of a second drug soon to be approved.
Researchers at the Israel Institute for Biological Research say widespread disinfecting won’t be necessary in hot weather.
After the monoclonal neutralizing antibody is patented, the institute will find an international manufacturer to mass produce it as a treatment.